Oseltamivir is first-line, of course--but this pulmonologist adds azithromycin for his vulnerable patients. Here's his rationale
This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.
This email was sent by: UBM Medica, a division of UBM Americas
535 Connecticut Avenue, Suite 300
Norwalk, CT, 06854, USA
